$3 million prize goes to duo whose research led to first sickle cell CRISPR therapy

Dr. Swee Lay Thein and Dr. Stuart Orkin won the $3 million Breakthrough Prize in Life Sciences for their work toward a ...

AI Reveals Negative Labels in Medical Records for Sickle Cell Patients

Negative descriptors were present in 15% of notes for sickle cell patients; 14% of notes for patients with opioid use ...
Healio

Patients with sickle cell disease using disease-modifying therapies more, but not enough

Please provide your email address to receive an email when new articles are posted on . Most patients with sickle cell disease are not using disease-modifying therapies. DMT use increased nearly 10% ...
European Medical Journal

Study Reveals Stigma Patterns in Sickle Cell Disease

Study finds sickle cell disease bias in clinical notes is linked more to opioid use than race or chronic pain in healthcare ...

Opioid use stigma may underlie clinician biases towards patients with sickle cell disease

In season 1, episode 2 of the popular show "The Pitt," a Black woman with sickle cell disease arrives at the emergency ...
AOL

Sickle cell gene therapy not approved for widespread NHS use in draft guidance

A world-first gene therapy for severe sickle cell disease has not been approved for widespread NHS use in new draft guidance. The National Institute for Health and Care Excellence (Nice) said it ...
The Hill

FDA approves first use of CRISPR gene editing to treat sickle cell disease

The Food and Drug Administration (FDA) on Friday approved a new therapy for treating sickle cell disease, marking the first instance of CRISPR gene editing receiving approval from federal regulators.
Crain's Chicago Business

UChicago among small group approved to use new treatments for sickle cell

The University of Chicago Medicine Comer Children’s Hospital is one of only nine centers nationwide authorized to use the newly approved CRISPR-based treatment for sickle cell disease in patients 12 ...
WebMD

Lyfgenia for Sickle Cell Disease

If you or someone you know has sickle cell disease (SCD), you may have heard of Lyfgenia, one of two gene therapies approved for this condition. Gene therapies are the only treatments for SCD that can ...